Koers Molecular Pharmacology (USA), Ltd. Other OTC
Aandelen
MLPH
US60852T1097
Biotechnologie & Medisch Onderzoek
Omzet 2013 | - | Omzet 2014 | - | Marktkapitalisatie | 1,12 mln. 1,02 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | - 0 | Nettowinst (verlies) 2014 | - 0 | EV/omzet 2013 | - |
Nettoschuld 2013 | 2,04 mln. 1,87 mln. | Nettoschuld 2014 | 2,2 mln. 2,03 mln. | EV/omzet 2014 | - |
K/w-verhouding 2013 |
-5,85
x | K/w-verhouding 2014 |
-9,54
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 99% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,52% | 111 mld. | |
+11,38% | 106 mld. | |
-12,64% | 22,24 mld. | |
+0,44% | 21,25 mld. | |
-4,18% | 18,97 mld. | |
-37,85% | 18,52 mld. | |
-8,58% | 16,81 mld. | |
+37,41% | 12,54 mld. | |
-23,95% | 8,09 mld. |